Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-08

FDA Approved: BROMFENAC OPHTHALMIC SOLUTION, 0.07% — Original Application (Apotex Corp.)

View source ↗

Summary

The FDA approved Apotex Corp.'s generic bromfenac ophthalmic solution 0.07% under an Original Application for relief of ocular pain and reduction of ocular infl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bromfenac ophthalmic solution, 0.07% (Bromfenac sodium)

Snippet

ORIG AP for BROMFENAC OPHTHALMIC SOLUTION, 0.07% (BROMFENAC SODIUM)